Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study Meeting Abstract
| Authors: | Modi, S.; Tsurutani, J.; Tamura, K.; Park, H.; Sagara, Y.; Murthy, R.; Iwata, H.; Krop, I. E.; Doi, T.; Redfern, C.; Moreno-Aspitia, A.; Redman, R.; Lee, C.; Sugihara, M.; Fujisaki, Y.; Takahashi, S. |
| Abstract Title: | Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study |
| Meeting Title: | 41st Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Dec 4-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000478677002270 |
| DOI: | 10.1158/1538-7445.Sabcs18-p6-17-02 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P6-17-02 -- Source: Wos |
